Time Source Company Announcement
23 Feb 2023 07:00 AM Appointment of Non-Executive Chair
23 Feb 2023 07:00 AM AIM Rule 17 Schedule 2(g) Update
23 Feb 2023 07:00 AM Appointment of Non-Executive Directors
23 Feb 2023 07:00 AM Notification of Full Year Results
23 Feb 2023 07:00 AM Q4 22 Divi, Letting Update & FY22 Valuation
23 Feb 2023 07:00 AM Appointment of new Chief Financial Officer
23 Feb 2023 07:00 AM Director/PDMR Shareholding
23 Feb 2023 07:00 AM Change of Broker
23 Feb 2023 07:00 AM Scrip Reference Price
23 Feb 2023 07:00 AM Directorate Change
23 Feb 2023 07:00 AM Dividend Declaration
23 Feb 2023 07:00 AM Darktrace Announces Availability of NEWSROOMT
23 Feb 2023 07:00 AM Kepler Trust Intelligence: New Research
23 Feb 2023 07:00 AM Share buyback-transaction in own shares
23 Feb 2023 07:00 AM Pre Close Trading Update
23 Feb 2023 07:00 AM Progress on direct balance sheet investment
23 Feb 2023 07:00 AM Issue of Equity
23 Feb 2023 07:00 AM 10 Year Exploration and Mining License for Tisma
23 Feb 2023 07:00 AM Share Buyback Programme Commences
23 Feb 2023 07:00 AM Results of Placing and Retail Offer
23 Feb 2023 07:00 AM Completion of Sinphuhorm Interest Acquisition
23 Feb 2023 07:00 AM Program Management Update and Sale of Tradesman
23 Feb 2023 07:00 AM Transaction in Own Shares
23 Feb 2023 07:00 AM Final Results
23 Feb 2023 07:00 AM Annual Financial Report
23 Feb 2023 07:00 AM 2022 Preliminary Results
23 Feb 2023 07:00 AM Placing Update
23 Feb 2023 07:00 AM AstraZeneca enters agreement with KYM for CMG901
23 Feb 2023 07:00 AM Dividend Declaration
23 Feb 2023 07:00 AM Director's Dealings
23 Feb 2023 07:00 AM Dividend Declaration
23 Feb 2023 07:00 AM Final Results and Notice of AGM
23 Feb 2023 07:00 AM Strategic Business Relationship and Project Update
23 Feb 2023 07:00 AM VALUATION UPDATE AND NOTICE OF HALF YEAR RESULTS
23 Feb 2023 07:00 AM 2022 Full Year Results
23 Feb 2023 07:00 AM Half Year Results
23 Feb 2023 07:00 AM Interim Results
23 Feb 2023 07:00 AM Trading Update and Notice of Results
23 Feb 2023 07:00 AM Avacta Therapeutics Division Science Day
23 Feb 2023 07:00 AM Half-year Report
23 Feb 2023 07:00 AM Company Update and Unaudited 31 December 2022 NAV
23 Feb 2023 07:00 AM Strategic Partnership, Equity Issue & TVR
23 Feb 2023 07:00 AM Serco wins CMS rebid valued at $690m
23 Feb 2023 07:00 AM Company Update
23 Feb 2023 07:00 AM 3rd Quarter Results
23 Feb 2023 07:00 AM Transaction in Own Shares
23 Feb 2023 07:00 AM Investment in the SVV III Limited Partnership
23 Feb 2023 07:00 AM Final Results
23 Feb 2023 07:00 AM 2022 full year results
23 Feb 2023 07:00 AM Change of Registered Office
UK 100

Latest directors dealings